| 1 | Melanoma antigens recognized by T cells and their use for immunotherapy | 1.8 | 14 | Citations (PDF) |
| 2 | RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer | 3.0 | 8 | Citations (PDF) |
| 3 | Challenges and experiences to develop a Japanese language course for international medical students in Japan: Maximising acquisition of Japanese language by applying adult learning theories | 0.2 | 2 | Citations (PDF) |
| 4 | TPT1 Supports Proliferation of Neural Stem/Progenitor Cells and Brain Tumor Initiating Cells Regulated by Macrophage Migration Inhibitory Factor (MIF) | 2.7 | 11 | Citations (PDF) |
| 5 | Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody 2022, 10, e004616 | | 108 | Citations (PDF) |
| 6 | Positive Effects of Oral Antibiotic Administration in Murine Chronic Graft-Versus-Host Disease | 3.2 | 16 | Citations (PDF) |
| 7 | Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors | 2.9 | 31 | Citations (PDF) |
| 8 | Prospective observational study of the efficacy of nivolumab in Japanese patients with advanced melanoma (CREATIVE study) | 1.2 | 20 | Citations (PDF) |
| 9 | Cascade of Inflammatory, Fibrotic Processes, and Stress-Induced Senescence in Chronic GVHD-Related Dry Eye Disease | 3.2 | 45 | Citations (PDF) |
| 10 | AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma | 5.9 | 68 | Citations (PDF) |
| 11 | Siglec-7 is a predictive biomarker for the efficacy of cancer vaccination against metastatic colorectal cancer | 1.1 | 15 | Citations (PDF) |
| 12 | Immune-resistant mechanisms in cancer immunotherapy | 1.6 | 62 | Citations (PDF) |
| 13 | Enhanced anti‐tumor effects of the PD‐1 blockade combined with a highly absorptive form of curcumin targeting STAT3 | 2.9 | 70 | Citations (PDF) |
| 14 | Senescence‐associated secretory phenotype promotes chronic ocular graft‐vs‐host disease in mice and humans | 2.3 | 44 | Citations (PDF) |
| 15 | Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy | 2.3 | 47 | Citations (PDF) |
| 16 | S-1 in combination with docetaxel as salvage therapy for patients with metastatic extramammary Paget's disease | 0.4 | 7 | Citations (PDF) |
| 17 | Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series | 2.1 | 24 | Citations (PDF) |
| 18 | NUAK2 localization in normal skin and its expression in a variety of skin tumors with YAP | 2.1 | 10 | Citations (PDF) |
| 19 | Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer | 4.2 | 113 | Citations (PDF) |
| 20 | Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter | 2.3 | 16 | Citations (PDF) |
| 21 | "Smart Eye Camera": An innovative technique to evaluate tear film breakup time in a murine dry eye disease model | 1.5 | 53 | Citations (PDF) |
| 22 | Analysis of the Tumor Reactivity of Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Lesion that Lost Major Histocompatibility Complex Class I Expression after Anti–PD-1 Therapy | 1.8 | 24 | Citations (PDF) |
| 23 | Combination Cisplatin-Epirubicin-Paclitaxel Therapy for Metastatic Extramammary Paget's Disease | 2.4 | 27 | Citations (PDF) |
| 24 | A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 | 11.0 | 49 | Citations (PDF) |
| 25 | Response of nivolumab monotherapy in 124 Japanese patients with advanced melanoma: Interim analysis of prospective observational study (CREATIVE study) | 8.1 | 3 | Citations (PDF) |
| 26 | Cluster of differentiation 30 expression in lacrimal gland and conjunctival tissues in patients with Sjögren's syndrome | 1.0 | 6 | Citations (PDF) |
| 27 | Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma | 1.9 | 24 | Citations (PDF) |
| 28 | Ocular Surface and Tear Film Characteristics in a Sclerodermatous Chronic Graft-Versus-Host Disease Mouse Model | 1.3 | 18 | Citations (PDF) |
| 29 | Functional Role of Lacrimal Gland Fibroblasts in a Mouse Model of Chronic Graft-Versus-Host Disease | 1.3 | 19 | Citations (PDF) |
| 30 | Involvement of local renin‐angiotensin system in immunosuppression of tumor microenvironment | 2.9 | 83 | Citations (PDF) |
| 31 | Novel elucidation and treatment of pancreatic chronic graft-versus-host disease in mice | 1.6 | 1 | Citations (PDF) |
| 32 | Therapeutic potential of tranilast for the treatment of chronic graft-versus-host disease in mice | 1.5 | 17 | Citations (PDF) |
| 33 | Pilot study of WT1 peptide‑pulsed dendritic cell vaccination with docetaxel in esophageal cancer | 1.1 | 12 | Citations (PDF) |
| 34 | Inhibition of Vascular Adhesion Protein‐1 for Treatment of Graft‐Versus‐Host Disease in Mice | 2.3 | 14 | Citations (PDF) |
| 35 | Generation of Human Immunosuppressive Myeloid Cell Populations in Human Interleukin-6 Transgenic NOG Mice | 3.3 | 65 | Citations (PDF) |
| 36 | Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy | 2.1 | 42 | Citations (PDF) |
| 37 | International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study | 45.2 | 1,981 | Citations (PDF) |
| 38 | Progression of Human Renal Cell Carcinoma via Inhibition of RhoA-ROCK Axis by PARG1 | 2.8 | 17 | Citations (PDF) |
| 39 | Functional analysis of KIF20A, a potential immunotherapeutic target for glioma | 1.9 | 62 | Citations (PDF) |
| 40 | Novel Treatment of Chronic Graft-Versus-Host Disease in Mice Using the ER Stress Reducer 4-Phenylbutyric Acid | 2.7 | 35 | Citations (PDF) |
| 41 | Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma | 1.0 | 28 | Citations (PDF) |
| 42 | Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma | 3.5 | 69 | Citations (PDF) |
| 43 | miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer | 1.1 | 25 | Citations (PDF) |
| 44 | Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer | 7.6 | 32 | Citations (PDF) |
| 45 | Autophagy-dependent regulation of tumor metastasis by myeloid cells | 1.5 | 10 | Citations (PDF) |
| 46 | Human PBMC-transferred murine MHC class I/II-deficient NOG mice enable long-term evaluation of human immune responses | 10.0 | 74 | Citations (PDF) |
| 47 | MIF: functions in brain and glioblastoma | 0.5 | 4 | Citations (PDF) |
| 48 | CHD7 promotes proliferation of neural stem cells mediated by MIF | 2.6 | 37 | Citations (PDF) |
| 49 | Targeting ALCAM in the cryo-treated tumour microenvironment successfully induces systemic anti-tumour immunity | 3.5 | 13 | Citations (PDF) |
| 50 | Cancer-induced heterogeneous immunosuppressive tumor microenvironments and their personalized modulation | 2.0 | 61 | Citations (PDF) |
| 51 | MIF Maintains the Tumorigenic Capacity of Brain Tumor–Initiating Cells by Directly Inhibiting p53 | 4.2 | 75 | Citations (PDF) |
| 52 | Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase | 1.8 | 180 | Citations (PDF) |
| 53 | Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies | 1.5 | 9 | Citations (PDF) |
| 54 | Synergistic antiproliferative effect of imatinib and adriamycin in platelet‐derived growth factor receptor‐expressing osteosarcoma cells | 2.9 | 20 | Citations (PDF) |
| 55 | Phase I pilot study of Wilms tumor gene 1 peptide‐pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer | 2.9 | 85 | Citations (PDF) |
| 56 | NUAK2
Amplification Coupled with
PTEN
Deficiency Promotes Melanoma Development via CDK Activation | 4.2 | 29 | Citations (PDF) |
| 57 | Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC | 2.6 | 59 | Citations (PDF) |
| 58 | Functional analysis of a novel glioma antigen, EFTUD1 | 0.9 | 10 | Citations (PDF) |
| 59 | TGF-β1 in Tumor Microenvironments Induces Immunosuppression in the Tumors and Sentinel Lymph Nodes and Promotes Tumor Progression | 1.6 | 36 | Citations (PDF) |
| 60 | Induction of Immunoregulatory CD271+ Cells by Metastatic Tumor Cells That Express Human Endogenous Retrovirus H | 4.2 | 55 | Citations (PDF) |
| 61 | Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours | 3.2 | 1,319 | Citations (PDF) |
| 62 | A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study) | 4.8 | 84 | Citations (PDF) |
| 63 | NOD-<i>Rag2<sup>null</sup> IL-2Rγ<sup>null</sup></i> Mice: An Alternative to NOG Mice for Generation of Humanized Mice | 11.1 | 26 | Citations (PDF) |
| 64 | Prognostic Significance of Interleukin-8 and CD163-Positive Cell-Infiltration in Tumor Tissues in Patients with Oral Squamous Cell Carcinoma | 1.5 | 67 | Citations (PDF) |
| 65 | Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma | 2.8 | 79 | Citations (PDF) |
| 66 | Cancer‐induced immunosuppressive cascades and their reversal by molecular‐targeted therapy | 2.6 | 20 | Citations (PDF) |
| 67 | Targeting FSTL1 Prevents Tumor Bone Metastasis and Consequent Immune Dysfunction | 4.2 | 82 | Citations (PDF) |
| 68 | Immunochemoradiotherapy for Patients with Oral Squamous Cell Carcinoma: Augmentation of OK-432-Induced Helper T Cell 1 Response by 5-FU and X-ray Irradiation | 2.9 | 21 | Citations (PDF) |
| 69 | Prognostic Impact of Expression of Bcl-2 and Bax Genes in Circulating Immune Cells Derived from Patients with Head and Neck Carcinoma | 2.9 | 18 | Citations (PDF) |
| 70 | Improvement of Cancer Immunotherapy by Combining Molecular Targeted Therapy | 1.7 | 23 | Citations (PDF) |
| 71 | Expression and localization of aging markers in lacrimal gland of chronic graft-versus-host disease | 2.7 | 31 | Citations (PDF) |
| 72 | Sox6 Up-Regulation by Macrophage Migration Inhibitory Factor Promotes Survival and Maintenance of Mouse Neural Stem/Progenitor Cells | 1.5 | 25 | Citations (PDF) |
| 73 | Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases | 4.8 | 159 | Citations (PDF) |
| 74 | Angiotensin II Type 1 Receptor Antagonist Attenuates Lacrimal Gland, Lung, and Liver Fibrosis in a Murine Model of Chronic Graft-Versus-Host Disease | 1.5 | 61 | Citations (PDF) |
| 75 | Presence and Physiologic Function of the Renin–Angiotensin System in Mouse Lacrimal Gland 2012, 53, 5416 | | 28 | Citations (PDF) |
| 76 | Fibroblast Growth Factor-2 Is an Important Factor that Maintains Cellular Immaturity and Contributes to Aggressiveness of Osteosarcoma | 2.6 | 33 | Citations (PDF) |
| 77 | Transplantation of side population cells restores the function of damaged exocrine glands through clusterin | 2.7 | 42 | Citations (PDF) |
| 78 | Cancer classification using the Immunoscore: a worldwide task force | 4.8 | 746 | Citations (PDF) |
| 79 | Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells | 1.8 | 87 | Citations (PDF) |
| 80 | Growth inhibition and apoptosis by an active component of OK-432, a streptococcal agent, via Toll-like receptor 4 in human head and neck cancer cell lines | 1.5 | 16 | Citations (PDF) |
| 81 | Accumulation of Secretory Vesicles in the Lacrimal Gland Epithelia Is Related to Non-Sjögren's Type Dry Eye in Visual Display Terminal Users | 1.5 | 28 | Citations (PDF) |
| 82 | Donor mesenchymal stem cells trigger chronic graft-versus-host disease following minor antigen-mismatched bone marrow transplantation | 0.0 | 0 | Citations (PDF) |
| 83 | Immune Suppression and Resistance Mediated by Constitutive Activation of Wnt/β-Catenin Signaling in Human Melanoma Cells | 0.8 | 156 | Citations (PDF) |
| 84 | Cancer‐testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer | 2.9 | 31 | Citations (PDF) |
| 85 | Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells | 3.0 | 60 | Citations (PDF) |
| 86 | CCL2 is critical for immunosuppression to promote cancer metastasis | 1.9 | 140 | Citations (PDF) |
| 87 | Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells | 19.9 | 79 | Citations (PDF) |
| 88 | Defining the critical hurdles in cancer immunotherapy | 4.8 | 149 | Citations (PDF) |
| 89 | Generation of Human Melanocytes from Induced Pluripotent Stem Cells | 1.5 | 104 | Citations (PDF) |
| 90 | The mechanisms of cancer immunoescape and development of overcoming strategies | 0.9 | 114 | Citations (PDF) |
| 91 | Adjuvant effects of formalin‐inactivated HSV through activation of dendritic cells and inactivation of myeloid‐derived suppressor cells in cancer immunotherapy | 2.8 | 10 | Citations (PDF) |
| 92 | AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma | 5.3 | 59 | Citations (PDF) |
| 93 | Downregulation of KIF23 suppresses glioma proliferation | 1.9 | 89 | Citations (PDF) |
| 94 | Identification of HLA‐A2‐ and A24‐restricted T‐cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy | 2.8 | 42 | Citations (PDF) |
| 95 | Aberrant Fatty Acid-Binding Protein-7 Gene Expression in Cutaneous Malignant Melanoma | 1.8 | 36 | Citations (PDF) |
| 96 | Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402 | 4.8 | 27 | Citations (PDF) |
| 97 | Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1 | 6.7 | 57 | Citations (PDF) |
| 98 | Involvement of Hyaluronan and Its Receptor CD44 with Choroidal Neovascularization 2009, 50, 4410 | | 35 | Citations (PDF) |
| 99 | Impairment of Plasmacytoid Dendritic Cells for IFN Production by the Ligand for Immunoglobulin-Like Transcript 7 Expressed on Human Cancer Cells | 4.5 | 34 | Citations (PDF) |
| 100 | Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells | 28.7 | 821 | Citations (PDF) |
| 101 | RNA helicase encoded by melanoma differentiation–associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease | 6.4 | 584 | Citations (PDF) |
| 102 | Simultaneous suppression of MITF and BRAFV600E enhanced inhibition of melanoma cell proliferation | 2.9 | 31 | Citations (PDF) |
| 103 | Activation of dendritic-like cells and neural stem/progenitor cells in injured spinal cord by GM-CSF | 1.9 | 42 | Citations (PDF) |
| 104 | Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology | 4.8 | 43 | Citations (PDF) |
| 105 | Epithelial Mesenchymal Transition in Human Ocular Chronic Graft-Versus-Host Disease | 2.8 | 77 | Citations (PDF) |
| 106 | Functional recovery after spinal cord injury in mice through activation of microglia and dendritic cells after IL‐12 administration | 2.0 | 50 | Citations (PDF) |
| 107 | Induction of protective and therapeutic antitumor immunity by a DNA vaccine with a glioma antigen, SOX6 | 2.8 | 22 | Citations (PDF) |
| 108 | Identification of a WT1 protein‐derived peptide, WT1187, as a HLA‐A*0206‐restricted, WT1‐specific CTL epitope | 1.0 | 18 | Citations (PDF) |
| 109 | Isolation and characterization of dendritic cells from common marmosets for preclinical cell therapy studies | 3.0 | 14 | Citations (PDF) |
| 110 | Autoreactive T-cell responses to myeloperoxidase in patients with antineutrophil cytoplasmic antibody-associated vasculitis and in healthy individuals | 1.5 | 11 | Citations (PDF) |
| 111 | A Pilot Study of Human Interferon Gene Therapy for Patients with Advanced Melanoma by in vivo Transduction Using Cationic Liposomes | 1.2 | 22 | Citations (PDF) |
| 112 | Helicobacter pylori eradication shifts monocyte Fcγ receptor balance toward inhibitory FcγRIIB in immune thrombocytopenic purpura patients | 6.8 | 117 | Citations (PDF) |
| 113 | Suppression of Alkali Burn-Induced Corneal Neovascularization by Dendritic Cell Vaccination Targeting VEGF Receptor 2 2008, 49, 2172 | | 21 | Citations (PDF) |
| 114 | Autoreactive T-cell responses to myeloperoxidase in patients with antineutrophil cytoplasmic antibody-associated vasculitis and in healthy individuals | 1.5 | 12 | Citations (PDF) |
| 115 | Inflammation and pathogenic fibrosis in human ocular chronic graft versus host disease | 4.5 | 1 | Citations (PDF) |
| 116 | Dendritic cell based personalized immunotherapy based on cancer antigen research | 5.8 | 16 | Citations (PDF) |
| 117 | Role of Heat Shock Protein 47, a Collagen-Binding Chaperone, in Lacrimal Gland Pathology in Patients with cGVHD 2007, 48, 1079 | | 42 | Citations (PDF) |
| 118 | Lentiviral Vector-Mediated Rnai and Its Use For Cancer Research | 1.7 | 31 | Citations (PDF) |
| 119 | Identification of a neuron-specific human gene, KIAA1110, that is a guanine nucleotide exchange factor for ARF1 | 1.5 | 11 | Citations (PDF) |
| 120 | Suppression of Choroidal Neovascularization by Dendritic Cell Vaccination Targeting VEGFR2 2007, 48, 4795 | | 15 | Citations (PDF) |
| 121 | Clinical significance of serum p53 antibodies in patients with ulcerative colitis and its carcinogenesis | 2.3 | 24 | Citations (PDF) |
| 122 | Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients | 2.8 | 51 | Citations (PDF) |
| 123 | T Helper Type 2-Biased Natural Killer Cell Phenotype in Patients with Pemphigus Vulgaris | 1.8 | 43 | Citations (PDF) |
| 124 | Dendritic Cells Transduced with Autoantigen FCRLA Induce Cytotoxic Lymphocytes and Vaccinate against Murine B-Cell Lymphoma | 1.8 | 14 | Citations (PDF) |
| 125 | Evaluation of platelet kinetics in patients with liver cirrhosis: Similarity to idiopathic thrombocytopenic purpura | 1.8 | 62 | Citations (PDF) |
| 126 | Neurogenic potential of progenitors derived from human circulating CD14
+
monocytes | 2.0 | 50 | Citations (PDF) |
| 127 | Possible involvement of allogeneic antigens recognised by donor-derived CD4+ cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy | 1.6 | 15 | Citations (PDF) |
| 128 | Bone Marrow Lacks a Transplantable Progenitor for Smooth Muscle Type α-Actin-Expressing Cells | 2.7 | 69 | Citations (PDF) |
| 129 | Endothelial Differentiation Potential of Human Monocyte-Derived Multipotential Cells | 2.7 | 120 | Citations (PDF) |
| 130 | Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis | 6.4 | 92 | Citations (PDF) |
| 131 | Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi | 2.8 | 59 | Citations (PDF) |
| 132 | Identification of a glioma antigen, GARC-1, using cytotoxic T lymphocytes induced by HSV cancer vaccine | 2.8 | 27 | Citations (PDF) |
| 133 | Systematic Identification of Human Melanoma Antigens Using Serial Analysis of Gene Expression (SAGE) | 1.6 | 34 | Citations (PDF) |
| 134 | Binding of β2–glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cellsBlood, 2005, 105, 1552-1557 | 3.6 | 95 | Citations (PDF) |
| 135 | Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope | 1.6 | 42 | Citations (PDF) |
| 136 | Novel autoantibodies to a voltage-gated potassium channel KV1.4 in a severe form of myasthenia gravis | 1.7 | 86 | Citations (PDF) |
| 137 | Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients | 2.8 | 25 | Citations (PDF) |
| 138 | Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis | 2.8 | 31 | Citations (PDF) |
| 139 | Immunological detection of altered signaling molecules involved in melanoma development | 6.8 | 10 | Citations (PDF) |
| 140 | Donor Fibroblast Chimerism in the Pathogenic Fibrotic Lesion of Human Chronic Graft-Versus-Host Disease 2005, 46, 4519 | | 59 | Citations (PDF) |
| 141 | Cardiomyogenic Potential of Mesenchymal Progenitors Derived from Human Circulating CD14+ Monocytes | 1.3 | 51 | Citations (PDF) |
| 142 | Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome | 1.6 | 49 | Citations (PDF) |
| 143 | Development of immunotherapy for cancer: Lessons from melanoma research | 0.7 | 0 | Citations (PDF) |
| 144 | Identification of human tumor antigens and its implications for diagnosis and treatment of cancer | 2.9 | 68 | Citations (PDF) |
| 145 | Single nucleotide polymorphisms of the inflammatory cytokine genes in adults with chronic immune thrombocytopenic purpura | 1.6 | 52 | Citations (PDF) |
| 146 | Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference | 5.2 | 181 | Citations (PDF) |
| 147 | Identification of an epigenetically silenced gene, RFX1, in human glioma cells using restriction landmark genomic scanning | 5.2 | 29 | Citations (PDF) |
| 148 | Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines | 5.2 | 100 | Citations (PDF) |
| 149 | Expression of a transcriptional factor, SOX6, in human gliomas | 1.4 | 37 | Citations (PDF) |
| 150 | Immunohistochemical analysis of SOX6 expression in human brain tumors | 1.4 | 17 | Citations (PDF) |
| 151 | Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease | 6.4 | 66 | Citations (PDF) |
| 152 | Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer | 2.8 | 15 | Citations (PDF) |
| 153 | Implantation of dendritic cells in injured adult spinal cord results in activation of endogenous neural stem/progenitor cells leading to de novo neurogenesis and functional recovery | 2.0 | 75 | Citations (PDF) |
| 154 | Optimization of an siRNA‐expression system with an improved hairpin and its significant suppressive effects in mammalian cells | 1.6 | 161 | Citations (PDF) |
| 155 | Defective vasculogenesis in systemic sclerosis | 45.2 | 268 | Citations (PDF) |
| 156 | Development of Immunotherapy for Pancreatic Cancer | 0.9 | 13 | Citations (PDF) |
| 157 | Augmentation of Antitumor Immune Responses by Multiple Intratumoral Inoculations of Replication-Conditional HSV and Interleukin-12 | 1.6 | 13 | Citations (PDF) |
| 158 | A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis | 9.5 | 100 | Citations (PDF) |
| 159 | Identification of Human Tumor Antigens Recognized by T-Cells and Their Use for Immunotherapy | 0.9 | 3 | Citations (PDF) |
| 160 | Autoreactive T cells to the P3A+ isoform of AChR α subunit in myasthenia gravis | 1.7 | 9 | Citations (PDF) |
| 161 | Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation | 1.7 | 286 | Citations (PDF) |
| 162 | Preferentially Expressed Antigen of Melanoma (PRAME) in the Development of Diagnostic and Therapeutic Methods for Hematological Malignancies | 1.0 | 44 | Citations (PDF) |
| 163 | A Novel Protein Highly Expressed in Testis Is Overexpressed in Systemic Sclerosis Fibroblasts and Targeted by Autoantibodies | 0.8 | 15 | Citations (PDF) |
| 164 | Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2 | 1.0 | 72 | Citations (PDF) |
| 165 | Suppression of autoreactive T-cell response to glycoprotein IIb/IIIa by blockade of CD40/CD154 interaction: implications for treatment of immune thrombocytopenic purpuraBlood, 2003, 101, 621-623 | 3.6 | 50 | Citations (PDF) |
| 166 | Periductal Area as the Primary Site for T-Cell Activation in Lacrimal Gland Chronic Graft-Versus-Host Disease 2003, 44, 1888 | | 126 | Citations (PDF) |
| 167 | Identification of a human glioma antigen, SOX6, recognized by patients' sera | 5.2 | 71 | Citations (PDF) |
| 168 | Restricted T-cell receptor β-chain usage by T cells autoreactive to β2–glycoprotein I in patients with antiphospholipid syndromeBlood, 2002, 99, 2499-2504 | 3.6 | 36 | Citations (PDF) |
| 169 | Rapid and efficient generation of lentivirally gene-modified dendritic cells from DC progenitors with bone marrow stromal cells | 1.0 | 17 | Citations (PDF) |
| 170 | Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: Relationship to thrombocytopenia with megakaryocytic hypoplasia | 6.4 | 81 | Citations (PDF) |
| 171 | Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: Application to enzyme-linked immunosorbent assay | 6.4 | 49 | Citations (PDF) |
| 172 | In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer | 3.7 | 47 | Citations (PDF) |
| 173 | Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV | 3.7 | 44 | Citations (PDF) |
| 174 | Title is missing! 2002 | | 1 | Citations (PDF) |
| 175 | Clinical significance of MART-1 and HLA-A2 expression and CD8+ T cell infiltration in melanocytic lesions in HLA-A2 phenotype patients | 2.1 | 14 | Citations (PDF) |
| 176 | Heterogeneous immunogenetic background in Japanese adults with myasthenia gravis | 1.3 | 16 | Citations (PDF) |
| 177 | Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura | 3.6 | 120 | Citations (PDF) |
| 178 | Autoreactive CD4+ T-cell clones to β2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding siteBlood, 2001, 98, 1889-1896 | 3.6 | 78 | Citations (PDF) |
| 179 | Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia | 1.6 | 76 | Citations (PDF) |
| 180 | Increase of oligodendrocyte progenitor cells after spinal cord injury | 2.0 | 70 | Citations (PDF) |
| 181 | Expression of the neural RNA‐binding protein Musashi1 in human gliomas | 3.6 | 156 | Citations (PDF) |
| 182 | Induction of antigen-specific human CD4+ T cell anergy by peripheral blood DC2 precursors | 2.4 | 135 | Citations (PDF) |
| 183 | Autoantibodies to the Amino-Terminal Fragment of β-Fodrin Expressed in Glandular Epithelial Cells in Patients with Sjögren’s Syndrome | 0.8 | 35 | Citations (PDF) |
| 184 | T cells that are autoreactive to β2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals | 6.4 | 74 | Citations (PDF) |
| 185 | Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis | 6.4 | 133 | Citations (PDF) |
| 186 | T Cell Immune Responses Against Melanoma and Melanocytes in Cancer and Autoimmunity | 0.0 | 44 | Citations (PDF) |
| 187 | Recognition of Shared Melanoma Antigens in Association With Major HLA-A Alleles by Tumor Infiltrating T Lymphocytes From 123 Patients With Melanoma | 1.6 | 133 | Citations (PDF) |
| 188 | Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma | 22.8 | 1,739 | Citations (PDF) |
| 189 | Immunotherapy Using T Cell Defined Tumor Antigens for Melanoma | 1.0 | 5 | Citations (PDF) |
| 190 | Melanosomal proteins as melanoma-specific immune targets | 1.0 | 95 | Citations (PDF) |
| 191 | Differential Expression of MART-1 in Primary and Metastatic Melanoma Lesions | 1.6 | 54 | Citations (PDF) |
| 192 | Immunobiology of Human Melanoma Antigens MART-1 and gp100 and their Use for Immuno-Gene Therapy | 2.7 | 89 | Citations (PDF) |
| 193 | Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1 | 1.0 | 99 | Citations (PDF) |
| 194 | Human tumor antigens recognized by T-cells | 1.6 | 120 | Citations (PDF) |
| 195 | Analysis of Expression of the Melanoma-Associated Antigens MART-1 and gp lOO in Metastatic Melanoma Cell Lines and in In Situ Lesions | 1.6 | 134 | Citations (PDF) |
| 196 | T-cell recognition of self peptides as tumor rejection antigens | 1.6 | 57 | Citations (PDF) |
| 197 | Human tumor antigens recognized by T cells | 3.7 | 189 | Citations (PDF) |
| 198 | Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes | 5.9 | 296 | Citations (PDF) |
| 199 | Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy | 3.4 | 520 | Citations (PDF) |
| 200 | Melanoma Tumor-Infiltrating Lymphocytes Derived from Four Distinct Anatomic Sites Obtained from a Single Patient | 1.6 | 8 | Citations (PDF) |
| 201 | Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line | 2.8 | 123 | Citations (PDF) |
| 202 | Molecular Characterization of Defective Antigen Processing in Human Prostate Cancer | 3.4 | 212 | Citations (PDF) |
| 203 | Recognition of neuroectodermal tumors by melanoma-specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crest | 3.2 | 24 | Citations (PDF) |
| 204 | T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. | 5.3 | 67 | Citations (PDF) |
| 205 | Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. | 5.3 | 886 | Citations (PDF) |
| 206 | Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. | 5.3 | 259 | Citations (PDF) |
| 207 | T-Cell Receptor Repertoire in Tumor-Infiltrating Lymphocytes. Analysis of Melanoma-Specific Long-Term Lines | 1.6 | 32 | Citations (PDF) |
| 208 | Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. | 5.3 | 1,020 | Citations (PDF) |
| 209 | T-Cell Recognition of Human Melanoma Antigens | 1.6 | 62 | Citations (PDF) |
| 210 | Expansion of Tumor-Infiltrating Lymphocytes from Human Tumors Using the T-Cell Growth Factors Interleukin-2 and Interleukin-4 | 1.6 | 16 | Citations (PDF) |
| 211 | Recognition of Shared Melanoma Antigens by Human Tumor-Infiltrating Lymphocytes | 1.6 | 25 | Citations (PDF) |
| 212 | Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo | 1.6 | 90 | Citations (PDF) |
| 213 | Mechanisms of immunologic antitumor therapy: lessons from the laboratory and clinical applications | 0.5 | 22 | Citations (PDF) |
| 214 | Prevention and reversal of delta-9-tetrahydrocannabinol induced depression of natural killer cell activity by interleukin-2 | 1.3 | 28 | Citations (PDF) |
| 215 | Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity | 1.3 | 29 | Citations (PDF) |
| 216 | Suppression by cannabinoids of the induction and function of murine cytotoxic T lymphocytes | 1.3 | 0 | Citations (PDF) |
| 217 | Chemoimmunotherapy of Spontaneous Mammary Tumors in C3H/OuJ Mice by Cyclophosphamide and Interleukin-2 | 2.6 | 0 | Citations (PDF) |
| 218 | Suppression by Cannabinoids of a Cloned Cell Line with Natural Killer Cell Activity | 2.1 | 26 | Citations (PDF) |
| 219 | MHC-compatible bone marrow stromal/stem cells trigger fibrosis by activating host T cells in a scleroderma mouse model | 1.0 | 40 | Citations (PDF) |
| 220 | GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab | 1.0 | 60 | Citations (PDF) |
| 221 | Enhancement of anti-tumor effects of PD-1 inhibitors by modulation of lipid metabolism in tumor microenvironment | 0.0 | 0 | Citations (PDF) |
